Robert William Atkinson
General Contractor in Raleigh, NC

License number
North Carolina 9114
Renew Date
Dec 10, 1979
Category
General Contractor
Type
Building
Address
Address
Rt 8 BOX 432, Raleigh, NC 27612
LicenseFiles verified this license of Jan 19, 2017 at the North Carolina Licensing Board for General Contractors.

Professional information

Robert Atkinson Photo 1

Clinical Research Associate I At Theorem Clinical Research
Position:
Clinical Research Associate I at Theorem Clinical Research
Location:
Raleigh-Durham, North Carolina Area
Industry:
Pharmaceuticals
Work:
Theorem Clinical Research - Raleigh, NC since Jul 2013 - Clinical Research Associate I Kinetigen, Inc. - Research Triangle Park, NC Feb 2013 - May 2013 - Clinical Pharmacology Associate ClinPharm Consulting - Research Triangle Park, NC Jun 2012 - May 2013 - Clinical Pharmacology Associate Pamlico Pharmaceutical Inc Jan 2011 - Feb 2012 - Associate Director of Chemistry Pamlico Pharmaceutical Inc May 2010 - Dec 2010 - Principal Research Investigator Pamlico Pharmaceutical Inc Jan 2010 - May 2010 - Senior Research Investigator Icagen Jan 2007 - Dec 2009 - Senior Research Investigator Icagen Feb 2003 - Dec 2006 - Senior Research Scientist Icagen Feb 2000 - Jan 2003 - Senior Scientist RTI International Jan 2000 - Feb 2000 - Research Associate RTI International Jan 1999 - Dec 1999 - Postdoctoral Research Fellow (Dr. F. Ivy Carroll)
Education:
Campbell University College of Pharmacy & Health Sciences 2012 - 2015
MSCR, Clinical Research Wake Forest University 1994 - 1999
Ph.D., Organic Chemistry
Skills:
Drug Discovery

Robert Atkinson Photo 2

Experienced Human Resources Generalist
Position:
Teacher at Hudson Memorial Children's Weekday Ministries
Location:
Raleigh-Durham, North Carolina Area
Industry:
Human Resources
Work:
Hudson Memorial Children's Weekday Ministries - Raleigh, NC since 2009 - Teacher MED3OOO Nov 2006 - Mar 2008 - Human Resources Manager MedCost, LLC Aug 1999 - Nov 2006 - Human Resources & Facilities Supervisor
Education:
Pfeiffer University 1997 - 1999
Master of Science (MS), Organizational Management University of North Carolina at Wilmington 1994 - 1997
BA, Communication Studies

Robert Atkinson Photo 3

Programmer/Analyst Intern At Progress Energy
Position:
Product Support at Entrinsik, Inc.
Location:
Raleigh-Durham, North Carolina Area
Industry:
Research
Work:
Entrinsik, Inc. - Raleigh-Durham, North Carolina Area since Jan 2013 - Product Support Progress Energy - Cary, NC May 2012 - Dec 2012 - Programmer/Analyst Intern Boddie-Noell Ent. - Raleigh-Durham, North Carolina Area Jun 2011 - May 2012 - Cashier CCCC Jun 2009 - Aug 2009 - Math Tutor Tands, Inc Nov 2007 - Aug 2009 - Cashier Food Lion Apr 2006 - Sep 2007 - Grocery Associate/Sales and Service Associate
Education:
NC State University 2009 - 2012
B.S; B.S, Computer Science; Applied Mathematics Coastal Carolina Community College 2008 - 2009
Associate of Arts, Pre-major Engineering
Interests:
Christ-centered life and work, software development, videogame design, applied mathematics, math modeling
Honor & Awards:
NCSU Dean's List, Phi Theta Kappa member, President's List for Coastal Carolina Community College

Robert Atkinson Photo 4

Pyrazolopyrimidine Compositions

US Patent:
7098335, Aug 29, 2006
Filed:
Nov 12, 2004
Appl. No.:
10/987089
Inventors:
Robert N. Atkinson - Raleigh NC, US
Michael F. Gross - Durham NC, US
Albert M. van Rhee - Durham NC, US
Assignee:
Icagen, Inc. - Durham NC
International Classification:
C07D 487/00, A61K 31/519
US Classification:
544281, 544280, 5142593
Abstract:
Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides pyrazolopyrimidines, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.

Robert Atkinson Photo 5

Heterocycles As Potassium Channel Modulators

US Patent:
8431608, Apr 30, 2013
Filed:
Feb 16, 2010
Appl. No.:
12/706574
Inventors:
Thomas Eugene Christos - Wake Forest NC, US
George S. Amato - Cary NC, US
Robert N. Atkinson - Raleigh NC, US
Maria Graciela Barolli - Morrisville NC, US
Mark J. Suto - Chapel Hill NC, US
Assignee:
Icagen Inc. - Durham NC
International Classification:
A61K 31/4188, C07D 235/00
US Classification:
514393, 5483027
Abstract:
Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides heterocycles, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders (e. g. , migraine, ataxia, Parkinson's disease, bipolar disorders, trigeminal neuralgia, spasticity, mood disorders, brain tumors, psychotic disorders, myokymia, seizures, epilepsy, seizure, retinal degeneration, hearing and vision loss, Alzheimer's disease, age-related memory loss, learning deficiencies, anxiety, neuronal degeneration and motor neuron diseases, maintaining bladder control or treating urinary incontinence) and as neuroprotective agents (e. g. , to prevent stroke and the like) by modulating potassium channels associated with the onset or recurrence of the indicated conditions.

Robert Atkinson Photo 6

2-Arylimidazo[1,2-B]Pyridazine, 2-Phenylimidazo[1,2-A]Pyridine, And 2-Phenylimidazo[1,2-A]Pyrazine Derivatives

US Patent:
2012017, Jul 12, 2012
Filed:
Dec 22, 2011
Appl. No.:
13/335072
Inventors:
Robert N. Atkinson - Raleigh NC, US
Andy J. Ommen - Laramie WY, US
James M. Veal - Apex NC, US
Kenneth H. Huang - Chapel Hill NC, US
Emilie D. Smith - Apex NC, US
International Classification:
A61K 31/5025, A61K 31/5377, C07D 471/04, C12N 5/02, A61K 31/519, A61K 31/4985, A61P 35/00, C07D 487/04, A61K 31/437
US Classification:
5142332, 544236, 514248, 544117, 546121, 514300, 544281, 5142591, 544350, 514249, 435375
Abstract:
Disclosed are compounds of formula (I):where X, Y, X, A, R, R, and Rare defined herein. Also disclosed are pharmaceutically acceptable salts of the compounds, compositions containing the compounds, and methods of using the compounds to treat, e.g., cancer.

Robert Atkinson Photo 7

Pyrazole-Amides And -Sulfonamides

US Patent:
7223782, May 29, 2007
Filed:
Nov 1, 2002
Appl. No.:
10/286304
Inventors:
Robert N. Atkinson - Raleigh NC, US
Michael F. Gross - Durham NC, US
Assignee:
Icagen, Inc. - Research Triangle Park NC
International Classification:
A61K 31/4155, C07D 231/12, C07D 231/14
US Classification:
514406, 5483741
Abstract:
Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides pyrazole-amides and -sulfonamides, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.

Robert Atkinson Photo 8

Arylsubstituted Thiazolotriazoles And Thiazoloimidazoles

US Patent:
2013008, Apr 4, 2013
Filed:
Sep 28, 2012
Appl. No.:
13/630946
Inventors:
Emilie D. Smith - Apex NC, US
Mark E. Fitzgerald - Durham NC, US
Rong Jiang - Fuquay Varina NC, US
Robert N. Atkinson - Raleigh NC, US
James M. Veal - Apex NC, US
Kenneth H. Huang - Chapel Hill NC, US
International Classification:
A61K 31/429, A61K 31/4725, A61P 9/10, C07D 513/04
US Classification:
514307, 548154, 514368, 546148
Abstract:
This disclosure relates to compounds, compositions and methods for the treatment of various disorders. In particular, the disclosure relates to thiazolotriazole and thiazoloimidazole compounds which agonize the activity of the protein TGR5.

Robert Atkinson Photo 9

Sulfonamide, Sulfamate, And Sulfamothioate Derivatives

US Patent:
2012007, Mar 29, 2012
Filed:
Sep 12, 2011
Appl. No.:
13/230443
Inventors:
Zhong Wang - Cupertino CA, US
Emilie D. Smith - Apex NC, US
James M. Veal - Apex NC, US
Kenneth H. Huang - Chapel Hill NC, US
Robert N. Atkinson - Raleigh NC, US
Rong Jiang - Fuquay Varina NC, US
International Classification:
A61K 31/53, A61K 31/519, A61P 25/28, A61P 35/00, A61P 29/00, C07D 487/04, C07D 495/04
US Classification:
514243, 544183, 544262, 5142621, 544278, 5142601, 544212, 514245
Abstract:
The disclosure provides biologically active compounds of formula (I):and pharmaceutically acceptable salts thereof, compositions containing these compounds, and methods of using these compounds in a variety applications, such as treatment of diseases or disorders associated with E1 type activating enzymes, and with Nedd8 activating enzyme (NAE) in particular.

Robert Atkinson Photo 10

Piperidines

US Patent:
7244744, Jul 17, 2007
Filed:
Nov 1, 2002
Appl. No.:
10/286662
Inventors:
Michael F. Gross - Durham NC, US
Robert N. Atkinson - Raleigh NC, US
Matthew S. Johnson - Durham NC, US
Assignee:
Icagen, Inc. - Research Triangle Park NC
International Classification:
A61K 31/445, C07D 401/04
US Classification:
514322, 546199
Abstract:
Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides substituted piperidines, and compositions containing these compounds. Also provided are methods using the compounds of the invention for the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.

General Contractor licenses in North Carolina